INS and neoplasm: Furthermore, in vivo studies have pointed out that metformin has more anti-tumor activities in mice receiving a high-energy diet, associated with hyperinsulinemia and accelerated tumor growth, than it does in mice receiving a balanced diet [125], indicating that the insulin-lowering effect of metformin likely contributes to its anti-tumor activity [126,127].